Syntax Bio
Latest round
- Series A
Last raised
- Jun 2026
Total raised
- $20M
Investors
- 17
About Syntax Bio
Based in Illinois, US, and founded in 2021 by co-founders Brad Merrill, Niko Balanis (CTO), and Ryan Clarke, Syntax Bio, Inc. develops and manufactures stem cell-based treatments. In June 2026, Syntax Bio, Inc. The core technology of Syntax Bio, the Cellgorithm platform, is designed to provide precise control over the differentiation of stem cells into specific cell types. Cellgorithms program cellular differentiation by providing epigenetic instructions that allow for the precise activation of genes sequentially. The technology also employs CRISPR-Cas9 gene-editing techniques to activate and deactivate specific genes as cells develop. The platform caters for a wide range of therapeutic areas, including immunology, neurology, and regenerative medicine.
Who invested in Syntax Bio
17 investors across 2 rounds
See all investors in Syntax Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Syntax Bio
Who invested in Syntax Bio?
Syntax Bio has 17 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Syntax Bio raised?
Syntax Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Syntax Bio last raise money?
Syntax Bio's most recent round on record is a Series A, in Jun 2026.
What does Syntax Bio do?
Based in Illinois, US, and founded in 2021 by co-founders Brad Merrill, Niko Balanis (CTO), and Ryan Clarke, Syntax Bio, Inc.
Where is Syntax Bio headquartered?
Syntax Bio is headquartered in Chicago, US.
Which VCs invest in companies like Syntax Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Syntax Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Syntax Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.